6,335
85
Blincyto, REGN1979, AMG420 BiTE® and 2019 American Society of Clinical Oncology update.
A thyroid cancer survivor shares valuable information about the disease and insight into the treatment process.
Selpercatinib is a precision cancer medicine that targets RET in some NSCLC patients.
Tepotinib is a novel precision cancer medicine capable of targeting NSCLC with MET 14 exon skipping alterations
Pivotal clinical trial fails to confirm benefit of 511 & Toca FC in recurrent High-Grade Glioma.
Keytruda is the standard of care for PD-1 + NSCLC. Longer follow continues to confirm advantage over chemotherapy.
Has cancer changed how you think about your body?
Opdivo® superior to Taxotere for treatment of recurrent NSCLC - Improves survival five fold!
Research suggests Metformin a widely used diabetic drug combined with a TKI may improve survival of EGFR mutated NSCLC.
2019 saw the greatest changes in the management of ovarian cancer in 20 years - learn more.
I thank Dr.Maleek, He helped me with a quick cure for my fibroid of more than 5 years, and its size…
Am Sharif Jenkins from united state, how can i say this to every one out there for more than 20…
Photodynamic therapy for neck cancer - good overview. Anyone have experience? …
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they could be…
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended but…
Optune looking for others to share their experience? How long do you wear it each day? How…
Can anyone share their experience with cold cap to prevent hair loss? I have learned that i can…
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
Several trials for GBM and other brain cancers at MSKCC: they keep them updated here:…
Anyone getting MRI instead of PET-CT?
